Stocks Telegraph

ASMB Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:ASMB

Assembly Biosciences, Inc.

$17.46
1.41+8.79%
At Close 4:00 PM
57.89
BESG ScoreESG Rating

ASMB FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

ASMB Income Statement


A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue8.533M5.785M7.163M00
cost of revenue32.00K32.00K84.00K116.00K126.00K
gross profit8.501M5.753M7.079M-116.00K-126.00K
gross profit ratio0.9960.9940.98800
research and development expenses16.259M11.879M11.006M10.824M12.523M
general and administrative expenses4.477M4.635M8.708M4.224M4.965M
selling and marketing expenses-32.00K-32.00K-84.00K00
selling general and administrative expenses4.445M4.603M8.624M4.224M4.965M
other expenses00000
operating expenses20.704M16.482M19.63M15.048M17.488M
cost and expenses20.736M16.514M19.714M15.048M17.488M
interest income1.457M1.652M1.622M628.00K592.00K
interest expense00000
depreciation and amortization32.00K32.00K84.00K116.00K126.00K
ebitda-12.171M-10.697M-12.467M-15.048M-17.362M
ebitda ratio-1.426-1.849-1.7400
operating income-12.203M-10.729M-12.551M-15.048M-17.488M
operating income ratio-1.43-1.855-1.75200
total other income expenses net1.457M1.652M1.622M628.00K592.00K
income before tax-10.746M-9.077M-10.929M-14.42M-16.896M
income before tax ratio-1.259-1.569-1.52600
income tax expense406.00K-11.276K33.00K-116.00K0
net income-11.152M-9.077M-10.962M-14.42M-16.896M
net income ratio-1.307-1.569-1.5300
eps-1.98-1.66-2.00-3.29-3.88
eps diluted-1.98-1.66-2.00-3.29-3.88
weighted average shs out5.643M5.483M5.483M4.38M4.355M
weighted average shs out dil5.643M5.483M5.483M4.38M4.355M
Graph

ASMB Balance Sheet


Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents19.208M18.749M19.841M26.656M21.623M
short term investments90.011M94.227M110.406M19.554M38.208M
cash and short term investments109.219M112.976M130.247M46.21M59.831M
net receivables400.00K343.00K43.00K100.00K342.00K
inventory001.00-100.00K0
other current assets3.312M3.849M3.497M3.462M3.908M
total current assets112.931M117.168M133.787M49.672M64.081M
property plant equipment net2.08M2.403M2.724M1.405M2.164M
goodwill00000
intangible assets00000
goodwill and intangible assets00000
long term investments00000
tax assets00646.00K00
other non current assets311.999K311.999K311.999K552.00K332.00K
total non current assets2.392M2.715M3.682M1.957M2.496M
other assets1.001.001.0000
total assets115.323M119.883M137.469M51.629M66.577M
account payables801.00K727.00K461.00K758.00K904.00K
short term debt1.295M1.145M1.22M869.00K1.702M
tax payables00000
deferred revenue33.06M32.771M30.915M2.733M2.733M
other current liabilities6.118M4.11M6.629M2.772M3.492M
total current liabilities41.274M38.753M39.225M7.132M8.831M
long term debt451.00K791.00K1.122M50.00K64.00K
deferred revenue non current38.916M47.738M55.379M2.733M2.733M
deferred tax liabilities non current0-47.738M646.00K-2.733M-2.733M
other non current liabilities047.738M02.733M2.733M
total non current liabilities39.367M48.529M57.147M2.783M2.797M
other liabilities00000
capital lease obligations451.00K791.00K1.122M919.00K1.766M
total liabilities80.641M87.282M96.372M9.915M11.628M
preferred stock00000
common stock6.00K5.00K5.00K53.00K52.00K
retained earnings-805.977M-794.825M-785.748M-774.786M-760.366M
accumulated other comprehensive income loss-293.00K-239.00K-81.00K-275.00K-325.00K
other total stockholders equity840.946M827.66M826.921M816.722M815.588M
total stockholders equity34.682M32.601M41.097M41.714M54.949M
total equity34.682M32.601M41.097M41.714M54.949M
total liabilities and stockholders equity115.323M119.883M137.469M51.629M66.577M
minority interest00000
total investments90.011M94.227M110.406M19.554M38.208M
total debt1.746M1.936M2.342M919.00K1.766M
net debt-17.462M-16.813M-17.499M-25.737M-19.857M
Graph

ASMB Cash Flow


A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

Date2024-06-302024-03-312023-12-312023-09-302023-06-30
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-1.467M-313.00K-169.00K
stock based compensation833.00K739.00K959.00K1.135M1.19M
change in working capital-6.209M-9.153M83.496M-880.00K4.394M
accounts receivables43.00K0-43.00K342.00K375.00K
inventory00000
accounts payables74.00K266.00K-297.00K-146.00K-320.00K
other working capital-6.326M-9.419M83.836M-1.076M4.339M
other non cash items174.00K-368.00K1.537M514.00K-2.273M
net cash provided by operating activities-17.102M-18.364M73.647M-13.848M-13.628M
investments in property plant and equipment-14.00K-14.00K-71.00K-136.00K-48.00K
acquisitions net0024.00K-19.017K48.00K
purchases of investments-31.179M-3.714M-108.307M-2.653M-22.962M
sales maturities of investments36.30M21.00M18.70M21.67M14.645M
other investing activites01.264M019.017K-48.00K
net cash used for investing activites5.107M17.272M-89.654M18.881M-8.365M
debt repayment00000
common stock issued12.454M09.192M054.00K
common stock repurchased00000
dividends paid00000
other financing activites000080.00K
net cash used provided by financing activities12.454M09.192M0134.00K
effect of forex changes on cash002.696M023.049M
net change in cash459.00K-1.092M-4.119M5.033M-21.859M
cash at end of period19.208M18.749M19.841M26.656M21.623M
cash at beginning of period18.749M19.841M23.96M21.623M43.482M
operating cashflow-17.102M-18.364M73.647M-13.848M-13.628M
capital expenditure-14.00K-14.00K-71.00K-136.00K-48.00K
free cash flow-17.116M-18.378M73.576M-13.984M-13.676M
Graph

Frequently Asked Questions

How did Assembly Biosciences, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?

A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, ASMB generated $8.53M in revenue last quarter, while its costs came in at $32.00K.

Last quarter, how much Gross Profit did Assembly Biosciences, Inc. report?

A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Assembly Biosciences, Inc. reported a $8.50M Gross Profit for the quarter ended Jun 30, 2024.

Have ASMB's Total Operating Expenses and Operating Income been favorable recently?

Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. ASMB incurred $20.70M worth of Operating Expenses, while it generated -$12.20M worth of Operating Income.

How much Net Income has ASMB posted recently?

The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Assembly Biosciences, Inc., the company generated -$11.15M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.

At the end of the last quarter, how much Cash and Equivalents did Assembly Biosciences, Inc. have?

The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Assembly Biosciences, Inc. as of the end of the last quarter was $19.21M.

What are ASMB's Total Net Receivables for the last quarter?

Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, ASMB had Total Net Receivables of $400.00K.

In terms of Total Assets and Current Assets, where did Assembly Biosciences, Inc. stand at?

An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of ASMB were $112.93M, while the Total Assets stand at $115.32M.

As of the last quarter, how much Total Debt did Assembly Biosciences, Inc. have?

The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of ASMB's debt was $1.75M at the end of the last quarter.

What were ASMB's Total Liabilities during the last reported quarter?

A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, ASMB reported total liabilities of $80.64M.

How much did ASMB's Working Capital change over the last quarter?

Working Capital Change for ASMB was -$6.21M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.

ASMB generated how much cash from operating activities?

An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. ASMB generated -$17.10M of Cash from Operating Activities during its recently reported quarter.

What was ASMB's latest reported Net Change in Cash?

An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. ASMB reported a $459.00K Net Change in Cash in the most recent quarter.

logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph